Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Teachey

Showing results (61-70 of 214) with videos related to

Pageof 22
Sort By:
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 23, 2018
Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe SepsisJessica K Signoff, Julie C Fitzgerald, David T Teachey, et al.
Anticancer Research|June 4, 2020
Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic LeukemiaErnest K Amankwah, Meenakshi Devidas, David T Teachey, et al.
Pediatric Blood & Cancer|June 18, 2011
Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient miceJennifer A Rothman, Rupali Das, David T Teachey, et al.
Pediatric Blood & Cancer|October 10, 2015
Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using SirolimusStacy L Cooper, Robert J Arceci, Christopher J Gamper, et al.
Expert Review of Anticancer Therapy|August 17, 2018
Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemiaAllison Barz Leahy, Caitlin W Elgarten, Stephan A Grupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord bloodBenjamin R Oshrine, Yimei Li, David T Teachey, et al.
Blood Cancer Discovery|January 11, 2022
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell TherapyKevin O McNerney, Amanda M DiNofia, David T Teachey, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2023
Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disordersAude Magerus, Anne Rensing-Ehl, V Koneti Rao, et al.
Immunologic Research|August 22, 2008
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative diseaseValerie I Brown, Alix E Seif, Gregor S D Reid, et al.
British Journal of Haematology|May 23, 2013
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimensDeepakBabu Chellapandian, Rupali Das, Kristin Zelley, et al.
Pageof 22

Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 23, 2018
Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe SepsisJessica K Signoff, Julie C Fitzgerald, David T Teachey, et al.
Anticancer Research|June 4, 2020
Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic LeukemiaErnest K Amankwah, Meenakshi Devidas, David T Teachey, et al.
Pediatric Blood & Cancer|June 18, 2011
Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient miceJennifer A Rothman, Rupali Das, David T Teachey, et al.
Pediatric Blood & Cancer|October 10, 2015
Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using SirolimusStacy L Cooper, Robert J Arceci, Christopher J Gamper, et al.
Expert Review of Anticancer Therapy|August 17, 2018
Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemiaAllison Barz Leahy, Caitlin W Elgarten, Stephan A Grupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 14, 2013
Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord bloodBenjamin R Oshrine, Yimei Li, David T Teachey, et al.
Blood Cancer Discovery|January 11, 2022
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell TherapyKevin O McNerney, Amanda M DiNofia, David T Teachey, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2023
Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disordersAude Magerus, Anne Rensing-Ehl, V Koneti Rao, et al.
Immunologic Research|August 22, 2008
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative diseaseValerie I Brown, Alix E Seif, Gregor S D Reid, et al.
British Journal of Haematology|May 23, 2013
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimensDeepakBabu Chellapandian, Rupali Das, Kristin Zelley, et al.
Pageof 22